Novanta Inc (1GSN) - Total Liabilities

Latest as of September 2025: €704.34 Million EUR ≈ $823.44 Million USD

Based on the latest financial reports, Novanta Inc (1GSN) has total liabilities worth €704.34 Million EUR (≈ $823.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Novanta Inc to assess how effectively this company generates cash.

Novanta Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how Novanta Inc's total liabilities have evolved over time, based on quarterly financial data. See 1GSN total equity for net asset value and shareholders' equity analysis.

Novanta Inc Competitors by Total Liabilities

The table below lists competitors of Novanta Inc ranked by their total liabilities.

Company Country Total Liabilities
E-L Financial Corp Ltd
TO:ELF
Canada CA$19.14 Billion
Sydbank A/S
CO:SYDB
Denmark Dkr181.94 Billion
Bilfinger SE
XETRA:GBF
Germany €2.15 Billion
Flughafen Wien Aktiengesellschaft
VI:FLU
Austria €710.15 Million
Guangdong Electric Power Development Co Ltd
SHE:000539
China CN¥144.85 Billion
PT Alamtri Resources Indonesia Tbk
JK:ADRO
Indonesia Rp1.42 Billion
Skyline Corporation
NYSE:SKY
USA $522.09 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Novanta Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Novanta Inc (1GSN) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novanta Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novanta Inc (2015–2024)

The table below shows the annual total liabilities of Novanta Inc from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 €642.81 Million
≈ $751.52 Million
+16.33%
2023-12-31 €552.60 Million
≈ $646.04 Million
-16.73%
2022-12-31 €663.63 Million
≈ $775.85 Million
-6.08%
2021-12-31 €706.59 Million
≈ $826.08 Million
+81.94%
2020-12-31 €388.37 Million
≈ $454.05 Million
-14.18%
2019-12-31 €452.56 Million
≈ $529.09 Million
+28.82%
2018-12-31 €351.32 Million
≈ $410.73 Million
-15.38%
2017-12-31 €415.16 Million
≈ $485.36 Million
+148.94%
2016-12-31 €166.77 Million
≈ $194.97 Million
-2.67%
2015-12-31 €171.34 Million
≈ $200.32 Million
--

About Novanta Inc

F:1GSN Germany Scientific & Technical Instruments
Market Cap
$4.27 Billion
€3.65 Billion EUR
Market Cap Rank
#3986 Global
#711 in Germany
Share Price
€102.00
Change (1 day)
-7.27%
52-Week Range
€84.50 - €123.00
All Time High
€171.00
About

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets las… Read more